Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

RDHL holding history

RedHill Biopharma Ltd. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RDHL overviewAll 13F holders of RDHLFull Q2 2026 holdings

Shares (Q2 2026)
1
Value
$1
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RDHL by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261$1<0.1%00.0%UnchangedHolders
Q1 20261$1<0.1%00.0%UnchangedHolders
Q4 20251$1<0.1%00.0%UnchangedHolders
Q3 20251$2<0.1%−1,801−99.9%ReducedHolders
Q2 20251,802$3.50K<0.1%+1,789+13,761.5%AddedHolders
Q1 202513$34<0.1%−2,200−99.4%ReducedHolders
Q4 20242,213$13.7K<0.1%+2,033+1,129.4%AddedHolders
Q3 2024180$1.57K<0.1%−180−50.0%ReducedHolders
Q2 2024360$134<0.1%−156−30.2%ReducedHolders
Q1 2024516$274<0.1%−60−10.4%ReducedHolders
Q4 2023576$842<0.1%+175+43.6%AddedHolders
Q3 2023401$205<0.1%−200−33.3%ReducedHolders
Q2 2023601$721<0.1%+175+41.1%AddedHolders
Q1 2023426$1.74K<0.1%−10,707−96.2%ReducedConverted for a 1-for-40 splitHolders
Q4 2022445,309$62.5K<0.1%+58,128+15.0%AddedHolders
Q3 2022387,181$195.0K<0.1%+242,959+168.5%AddedHolders
Q2 2022144,222$125.0K<0.1%+105,106+268.7%AddedHolders
Q1 202239,116$99.0K<0.1%+3,596+10.1%AddedHolders
Q4 202135,520$92.0K<0.1%+1,479+4.3%AddedHolders
Q3 202134,041$156.0K<0.1%−9,653−22.1%ReducedHolders
Q2 202143,694$301.0K<0.1%+24,855+131.9%AddedHolders
Q1 202118,839$137.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.